CymaBay Pulls Off Another Win With PBC Liver Disease Study
CymaBay Therapeutics posted a huge gain to start off the week after the company reported results from a late-stage clinical study for the treatment of primary biliary cholangitis.
CymaBay Therapeutics posted a huge gain to start off the week after the company reported results from a late-stage clinical study for the treatment of primary biliary cholangitis.
Clorox reported better than expected fiscal fourth-quarter financial results before the markets opened on Monday, due largely to stronger consumer demand.
GW Pharmaceuticals shares popped early on Monday morning after the company announced that it received a key approval from the FDA for Epidiolex to treat certain seizures.
This is a preview of a few of the most anticipated quarterly reports due this week, including CVS Health, Uber and Walt Disney.
24/7 Wall St. has tracked 10 earnings reports from the last week of July in which the earnings news was very positive and the stock price surged alongside the report.
When Merck & Co. (NYSE: MRK | MRK Price Prediction) reported its second-quarter financial results before the markets opened on Wednesday, the pharmaceutical giant said that it had earnings per share (EPS) of $1.37…
Caterpillar reported better than expected quarterly results before the markets opened on Friday, but expectations were rather low.
Search engine behemoth Google reported second-quarter earnings per share of $10.13 and $38.30 billion in revenue. Consensus estimates called for $8.34 in EPS and $37.36 billion in revenue.
Apple reported third fiscal quarter earnings per share of $2.58 and $59.7 billion in revenue, compared with consensus estimates that called for $2.04 in EPS and $52.25 billion in revenue. The company also announced…
After markets closed on Thursday, e-commerce giant Amazon reported second-quarter earnings per share of $10.30 and $88.91 billion in revenue. The consensus estimates called for $1.46 in EPS and $81.53 billion in revenue.
Social media giant Facebook on Thursday reported $1.80 in earnings per share on $18.69 billion in revenue compared to analysts' consensus estimate calling for $1.39 in EPS and $17.4 billion in revenue.
Johnson & Johnson has announced that it will launch its human study for its lead vaccine candidate in the United States and Belgium.
Kraft Heinz reported better than expected second-quarter financial results before the markets opened on Thursday, but shares fell anyway.
Edesa Biotech joins the list of COVID-19 stocks, as the company is making headway with regulatory agencies for its late-stage study. Investors were quick to give this firm the coronavirus bump, more than doubling…
Procter & Gamble reported better than exepcted fiscal fourth-quarter financial results before the markets opened on Thursday.
Digital payment firm PayPal reported $1.07 in earnings per share (EPS) and $5.26 billion in revenue in the second quarter, compared with consensus estimates that called for $0.88 in EPS on $4.99 billion in…
L Brands surged on Wednesday to a new 52-week high after the company unveiled a new cost-cutting strategy that it will employ.
Cybersecurity firm FireEye saw record numbers in its most recent quarter as COVID-19 has placed much more emphasis on the industry.
Shopify stock rallied after the e-commerce company reported better than expected quarterly results before the opening bell on Wednesday.
Spotify Technology reported disappointing second-quarter financial results before the markets opened on Wednesday, despite solid user growth in the period.